Bli medlem
Bli medlem

Du är här

2016-10-18

Getinge Group: Getinge Interim Report January-September 2016

Press releaseGothenburg, October 18, 2016

Third quarter of 2016 in brief

· Order intake decreased 3.0% to SEK 7,176 M (7,397). The order
intake declined organically by 3.2%.

· Net sales increased 0.1% to SEK 6,929 M (6,925). Net sales
increased organically by 0.2%.

· Gross margin increased to 47.3% (46.8).
· EBITA* improved 16.3% to SEK 963 M (828).
· Restructuring costs increased to SEK 732 M (213). SEK 628 M
comprises a provision for the FDA-related remediation program,
write-down of an R&D project and costs for changes among senior
executives.

· Profit before tax decreased 146.2% to SEK -110 M (238), due to
increased restructuring costs.

· Earnings per share decreased to SEK -0.36 (0.73).
· Good cost control as a consequence of the efficiency-enhancement
program, Big 5.

· Changes to Getinge Executive Team, Acting CEO, new CFO and HR
Director.

· FDA update, SEK 400 M provision related to the remediation
program.

· Changed outlook, moderately negative sales growth for the full
year.

· Key event after the reporting period, further developed and
focused strategy, and preparation for distribution of Patient &
Post-Acute Care to shareholders of Getinge.

January-September 2016 in brief

· Order intake decreased 2.5% to SEK 21,560 M (22,105). The order
intake fell organically by 0.7%.

· Net sales decreased 2.8% to SEK 20,233 M (20,818). Net sales fell
organically by 1.1%.

· Gross margin amounted to 46.7% (46.7).
· EBITA* improved 4.9% to SEK 2,371 M (2,260).
· Restructuring costs increased to SEK 992 M (483).
· Profit before tax decreased 42.8% to SEK 358 M (626).
· Earnings per share decreased to SEK 1.03 (1.81).
Financial summary

MSEK Q3 Q3 Change Jan-Sep Jan-Sep 2015 Change % FY2015
2016 2015 % 2016
Order intake 7 176 7 397 -3.0% 21 560 22 105 -2.5% 30 431
Net sales 6 929 6 925 0.1% 20 233 20 818 -2.8% 30 235
Gross Profit 3 275 3 240 1.1% 9 453 9 713 -2.7% 14 163
Gross margin 47.3% 46.8% 0.5% 46.7% 46.7% 0.0% 46.8%
EBITA* 963 828 16.3% 2 371 2 260 4.9% 4 179
EBITA 13.9% 12.0% 1.9% 11.7% 10.9% 0.8% 13.8%
margin*
Operating 49 421 -88.4% 838 1 184 -29.2% 2 729
profit
Profit -110 238 -146.2% 358 626 -42.8% 1 997
before tax
Net profit -81 174 -146.6% 261 457 -42.9% 1 457

Earnings per -0.36 0.73 -149.3% 1.03 1.81 -43.1% 5.83
share, SEK
Cash flow 724 0.1% 1 888 1 974 -4.4% 3 458
from 725
operations

* before restructuring, acquisition and integration cost

For further information, please contact:
Kornelia Rasmussen
Executive Vice President Group Communications
Phone: +46 (0)10 335 58 10
E-mail: kornelia.rasmussen@getinge.com

Getinge Group is a leading global provider of innovative solutions for
operating rooms, intensive-care units, hospital wards, sterilization
departments, elderly care and for life science companies and
institutions. Getinge's unique customer offering mirrors the
hospital's organization and value chain, and the solutions are used
before, during and after the patients' hospital stay. Based on
first-hand experience and close partnerships, Getinge provides
innovative healthcare solutions that improve every-day life for
people, today and tomorrow.

This information is information that Getinge AB is obliged to make
public pursuant to the EU Market Abuse Regulation. The information
was submitted for publication, through the agency of the contact
person set out above, at 13:00 p.m. CET on October 18, 2016

-----------------------------------------------------------
http://news.cision.com/getinge-group/r/getinge-interim-report-january-se...
http://mb.cision.com/Main/942/2103262/576419.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.